Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL942646 | 0.69 | ALDH1A1 (0.39) | ALDH1A1TSHRLMNACYP3A4NFKB1 | |
| SCHEMBL5538355 | 0.68 | CYP2D6 (0.35) | — | |
| SCHEMBL5532692 | 0.68 | ALDH1A1 (0.38) | ALDH1A1TSHRLMNACYP3A4NFKB1 | |
| SCHEMBL5138301 | 0.68 | CYP1A2 (0.43) | ALDH1A1TSHRLMNACYP3A4NFKB1 | |
| SCHEMBL13164473 | 0.67 | ALDH1A1 (0.53) | ALDH1A1TSHRLMNACYP3A4NFKB1 | |
| SCHEMBL27410073 | 0.67 | CYP1A2 (0.33) | ALDH1A1LMNAHSD17B10 | |
| SCHEMBL943319 | 0.67 | ALDH1A1 (0.40) | ALDH1A1TSHRLMNACYP3A4NFKB1 | |
| SCHEMBL944287 | 0.67 | ALDH1A1 (0.37) | ALDH1A1TSHRLMNACYP3A4NFKB1 | |
| SCHEMBL942978 | 0.67 | ALDH1A1 (0.37) | ALDH1A1TSHRLMNACYP3A4NFKB1 | |
| SCHEMBL17192924 | 0.66 | FDPS (0.34) | ALDH1A1TSHRLMNACYP3A4NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070055081-A1 | Processes for production of alpha-aminooxyketones and alpha-hydroxyketones | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2007-03-08 | — | — | US | disclosed |
| EP-1717221-A1 | PROCESSES FOR PRODUCTION OF ALPHA-AMINOOXYKETONES AND ALPHA-HYDROXYKETONES | Japan Science and Technology Agency (JP) | 2006-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070055081-A1 | Processes for production of alpha-aminooxyketones and alpha-hydroxyketones | KHK, HCCS, XDH | ALDH1A1 2256/4885TSHR 4535/4885LMNA 3219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.